tiprankstipranks
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market
NRSN
Neurosense Therapeutics Ltd.
RESEARCH TOOLSreports

Neurosense Therapeutics Ltd. (NRSN) Income Statement

201 Followers

Neurosense Therapeutics Ltd. Income Statement

Last quarter (Q2 2025), Neurosense Therapeutics Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Neurosense Therapeutics Ltd.'s net income was $-2.35M. See Neurosense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -89.00K$ -3.00K
Operating Expenses
$ 11.09M$ 9.90M$ 12.05M$ 13.46M$ 5.59M
Depreciation and Amortization
$ 16.00K$ 22.00K$ 21.00K$ 89.00K$ 3.00K
EBITDA
$ -11.07M$ -9.88M$ -9.64M$ -12.23M$ -2.88M
Operating Income
$ -11.09M$ -9.90M$ -12.05M$ -13.55M$ -5.59M
Other Income/Expenses
$ -40.00K$ -308.00K$ 1.94M$ 1.21M$ 1.55M
Pretax Income
$ -11.13M$ -10.21M$ -10.11M$ -12.34M$ -4.04M
Net Income
$ -11.13M$ -10.21M$ -10.11M$ -12.34M$ -4.04M
Per Share Metrics
Basic EPS
$ -0.44$ -0.55$ -0.83$ -1.07$ -0.23
Diluted EPS
$ -0.44$ -0.55$ -0.83$ -1.07$ -0.23
Weighted Average Shares Outstanding
 25.48M 18.60M 13.64M 11.51M 10.86M
Weighted Average Shares Outstanding (Diluted)
 25.48M 18.60M 13.64M 11.51M 10.86M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History